AIM logo

AIM ImmunoTech Inc.


AIM: AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alferon N Injection for a category of STD infection. Clinical trials of Ampligen include studies of cancer patients with renal cell carcinoma, malignant melanoma, colorectal cancer, advanced recurrent ovarian cancer and triple negative metastatic breast cancer. The company is also advancing Ampligen as a potential treatment for COVID-19. FDA has authorized the first human trial assessing the safety and effectiveness of Ampligen in combination with interferon alfa-2b, in cancer patients with COVID-19.


Show AIM Financials

Consumer Interest
SEC Filings

Recent trades of AIM by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by AIM's directors and management

Government lobbying spending instances

  • $40,000 Apr 20, 2022 Issue: Pharmacy Health Issues
  • $40,000 Jan 10, 2022 Issue: Pharmacy Health Issues
  • $40,000 Oct 20, 2021 Issue: Pharmacy Health Issues
  • $40,000 Jul 12, 2021 Issue: Health Issues Pharmacy
  • $30,000 Apr 20, 2021 Issue: Pharmacy Health Issues
  • $30,000 Jan 21, 2021 Issue: Health Issues Pharmacy
  • $30,000 Oct 19, 2020 Issue: Health Issues Pharmacy
  • $30,000 Jul 18, 2020 Issue: Health Issues Pharmacy
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of AIM in WallStreetBets Daily Discussion

AIM News

Recent insights relating to AIM

CNBC Recommendations

Recent picks made for AIM stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AIM

Corporate Flights

Flights by private jets registered to AIM